For research use only. Not for therapeutic Use.
cFMS Receptor Inhibitor IV（Cat No.:I042673）is a small molecule compound designed to selectively inhibit the cFMS receptor, also known as CSF1R (colony-stimulating factor 1 receptor). This receptor plays a crucial role in the regulation of macrophage development, survival, and function. By blocking cFMS receptor signaling, the inhibitor aims to modulate immune responses, reduce inflammation, and potentially impact the tumor microenvironment in cancer therapy. It is being studied for its therapeutic potential in treating inflammatory diseases, cancer, and other conditions driven by macrophage activation.
| CAS Number | 959626-45-0 |
| Synonyms | 5-cyano-N-[2,5-di(piperidin-1-yl)phenyl]furan-2-carboxamide |
| Molecular Formula | C22H26N4O2 |
| Purity | ≥95% |
| IUPAC Name | 5-cyano-N-[2,5-di(piperidin-1-yl)phenyl]furan-2-carboxamide |
| InChI | InChI=1S/C22H26N4O2/c23-16-18-8-10-21(28-18)22(27)24-19-15-17(25-11-3-1-4-12-25)7-9-20(19)26-13-5-2-6-14-26/h7-10,15H,1-6,11-14H2,(H,24,27) |
| InChIKey | FQGXFVDABCBEFW-UHFFFAOYSA-N |
| SMILES | C1CCN(CC1)C2=CC(=C(C=C2)N3CCCCC3)NC(=O)C4=CC=C(O4)C#N |
